Q1 2023 Pharming Group NV Earnings Call Transcript
Good morning or good afternoon, ladies and gentlemen, and welcome to our first quarter 2023 results call. And before I go into the call, I would like to have the next slide and show you the forward-looking statement slide as we will be making some forward-looking statements that are based upon our future expectations and our current expectations and assumptions. And as you know, they may change. And without having said that, next slide, please. I'm here with my 3 colleagues, Anurag Relan, our Chief Medical Officer; Stephen Toor, our Chief Commercial Officer; and Jeroen Wakkerman, our Chief Financial Officer.
And they will be speaking after me and I will start with a brief introduction. So next slide please, and then the next one as well. So basically, what Pharming is all about is that we are building a sustainable rare business. And that rare business will be able to be funded from the positive cash flows that we continue to generate from RUCONEST. And you have seen over the last quarters that these cash flows fromÂ
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
